OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 146 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,000 | -33.3% | 13,270 | +487.2% | 0.00% | – |
| Q3 2014 | $9,000 | -40.0% | 2,260 | -6.8% | 0.00% | – |
| Q2 2014 | $15,000 | +7.1% | 2,425 | +12.8% | 0.00% | – |
| Q1 2014 | $14,000 | +40.0% | 2,150 | +30.3% | 0.00% | – |
| Q4 2013 | $10,000 | -98.9% | 1,650 | -98.9% | 0.00% | -100.0% |
| Q3 2013 | $925,000 | +6.4% | 150,672 | +1.5% | 0.00% | 0.0% |
| Q2 2013 | $869,000 | – | 148,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |